Antiviral effect of cetylpyridinium chloride in mouthwash on SARS-CoV-2

Sci Rep. 2022 Aug 18;12(1):14050. doi: 10.1038/s41598-022-18367-6.

Abstract

Cetylpyridinium chloride (CPC), a quaternary ammonium compound, which is present in mouthwash, is effective against bacteria, fungi, and enveloped viruses. This study was conducted to explore the antiviral effect of CPC on SARS-CoV-2. There are few reports on the effect of CPC against wild-type SARS-CoV-2 at low concentrations such as 0.001%-0.005% (10-50 µg/mL). Interestingly, we found that low concentrations of CPC suppressed the infectivity of human isolated SARS-CoV-2 strains (Wuhan, Alpha, Beta, and Gamma) even in saliva. Furthermore, we demonstrated that CPC shows anti-SARS-CoV-2 effects without disrupting the virus envelope, using sucrose density analysis and electron microscopic examination. In conclusion, this study provided experimental evidence that CPC may inhibit SARS-CoV-2 infection even at lower concentrations.

MeSH terms

  • Antiviral Agents / pharmacology
  • COVID-19 Drug Treatment*
  • Cetylpyridinium* / pharmacology
  • Humans
  • Mouthwashes / pharmacology
  • SARS-CoV-2

Substances

  • Antiviral Agents
  • Mouthwashes
  • Cetylpyridinium